BioVie Stock (NASDAQ: BIVI) stock price, news, charts, stock research, profile.
You can purchase shares of BioVie (NASDAQ:BIVI) through any online brokerage.
Other companies in BioVie’s space includes: Alzamend Neuro (NASDAQ:ALZN), Addex Therapeutics (NASDAQ:ADXN), Coeptis Therapeutics (NASDAQ:COEP), Can Fite Biofarma (AMEX:CANF) and GlycoMimetics (NASDAQ:GLYC).
BioVie has a consensus price target of $10.80.
The stock price for BioVie (NASDAQ: BIVI) is $1.16 last updated October 1, 2024 at 6:55 PM EDT.
There are no upcoming dividends for BioVie.
BioVie’s Q1 earnings are confirmed for Wednesday, November 6, 2024.
There is no upcoming split for BioVie.
BioVie is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.